Login / Signup

Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth. Authors' reply.

Vince B C BiemansFrank HoentjenMarieke J Pierik
Published in: Alimentary pharmacology & therapeutics (2020)
Keyphrases
  • randomized controlled trial
  • rheumatoid arthritis
  • systematic review
  • ulcerative colitis
  • patients with inflammatory bowel disease